| Product Code: ETC9972032 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Oncology Devices Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Oncology Devices Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Oncology Devices Market - Industry Life Cycle |
3.4 United States (US) Oncology Devices Market - Porter's Five Forces |
3.5 United States (US) Oncology Devices Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 United States (US) Oncology Devices Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 United States (US) Oncology Devices Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in the US |
4.2.2 Technological advancements in oncology devices |
4.2.3 Growing demand for minimally invasive procedures |
4.2.4 Rising healthcare expenditure and investments in oncology care |
4.2.5 Favorable reimbursement policies for oncology treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for oncology devices |
4.3.2 High cost associated with oncology devices and treatments |
4.3.3 Limited access to advanced oncology care in certain regions |
4.3.4 Competition from alternative treatment modalities |
4.3.5 Challenges in adoption of new technologies by healthcare providers |
5 United States (US) Oncology Devices Market Trends |
6 United States (US) Oncology Devices Market, By Types |
6.1 United States (US) Oncology Devices Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Oncology Devices Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 United States (US) Oncology Devices Market Revenues & Volume, By Rachytherapy Devices, 2021- 2031F |
6.1.4 United States (US) Oncology Devices Market Revenues & Volume, By Endoscopic Devices, 2021- 2031F |
6.2 United States (US) Oncology Devices Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Oncology Devices Market Revenues & Volume, By Cancer Research Institutes, 2021- 2031F |
6.2.3 United States (US) Oncology Devices Market Revenues & Volume, By Cancer Hospitals, 2021- 2031F |
7 United States (US) Oncology Devices Market Import-Export Trade Statistics |
7.1 United States (US) Oncology Devices Market Export to Major Countries |
7.2 United States (US) Oncology Devices Market Imports from Major Countries |
8 United States (US) Oncology Devices Market Key Performance Indicators |
8.1 Adoption rate of minimally invasive oncology devices |
8.2 Number of research and development partnerships in the oncology devices sector |
8.3 Rate of utilization of oncology devices in outpatient settings |
8.4 Patient satisfaction scores related to oncology device usage |
8.5 Number of clinical trials involving oncology devices in the US |
9 United States (US) Oncology Devices Market - Opportunity Assessment |
9.1 United States (US) Oncology Devices Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 United States (US) Oncology Devices Market Opportunity Assessment, By Application, 2021 & 2031F |
10 United States (US) Oncology Devices Market - Competitive Landscape |
10.1 United States (US) Oncology Devices Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Oncology Devices Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here